| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
MediciNova Inc (NASDAQ: MNOV)
MNOV Technical Analysis
4
| As on 31st Oct 2025 MNOV STOCK Price closed @ 1.66 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.66 & Strong Buy for SHORT-TERM with Stoploss of 1.38 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MNOVSTOCK Price
| Open | 1.36 | Change | Price | % |
| High | 1.96 | 1 Day | 0.47 | 39.50 |
| Low | 1.20 | 1 Week | 0.44 | 36.07 |
| Close | 1.66 | 1 Month | 0.39 | 30.71 |
| Volume | 47419412 | 1 Year | 0.14 | 9.21 |
| 52 Week High 2.38 | 52 Week Low 1.13 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| NVDA | 202.49 | -0.20% |
| AMZN | 244.22 | 9.58% |
| OPEN | 7.77 | 5.86% |
| LMDX | 0.02 | 0.00% |
| ONDS | 6.44 | 2.38% |
| AKTS | 0.04 | 0.00% |
| BYND | 1.66 | 0.61% |
| PLUG | 2.69 | 1.51% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| MNOV Daily Charts |
MNOV Intraday Charts |
Whats New @ Bazaartrend |
MNOV Free Analysis |
|
|
MNOV Important Levels Intraday
| RESISTANCE | 3.12 |
| RESISTANCE | 2.65 |
| RESISTANCE | 2.36 |
| RESISTANCE | 2.07 |
| SUPPORT | 1.25 |
| SUPPORT | 0.96 |
| SUPPORT | 0.67 |
| SUPPORT | 0.20 |
MNOV Forecast November 2025
| 4th UP Forecast | 2.18 |
| 3rd UP Forecast | 2.01 |
| 2nd UP Forecast | 1.91 |
| 1st UP Forecast | 1.81 |
| 1st DOWN Forecast | 1.51 |
| 2nd DOWN Forecast | 1.41 |
| 3rd DOWN Forecast | 1.31 |
| 4th DOWN Forecast | 1.14 |
MNOV Weekly Forecast
| 4th UP Forecast | 1.97 |
| 3rd UP Forecast | 1.87 |
| 2nd UP Forecast | 1.81 |
| 1st UP Forecast | 1.75 |
| 1st DOWN Forecast | 1.57 |
| 2nd DOWN Forecast | 1.51 |
| 3rd DOWN Forecast | 1.45 |
| 4th DOWN Forecast | 1.35 |
MNOV Forecast2025
| 4th UP Forecast | 4.42 |
| 3rd UP Forecast | 3.53 |
| 2nd UP Forecast | 2.99 |
| 1st UP Forecast | 2.44 |
| 1st DOWN Forecast | 0.88 |
| 2nd DOWN Forecast | 0.33 |
| 3rd DOWN Forecast | -0.21 |
| 4th DOWN Forecast | -1.1 |
MediciNova Inc ( NASDAQ USA Symbol : MNOV )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MNOV Business Profile
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. The company has a collaboration agreement with BioComo and Mie University for joint development of a SARS-CoV-2 vaccine. MediciNova, Inc. was founded in 2000 and is headquartered in La Jolla, California. Address: 4275 Executive Square, La Jolla, CA, United States, 92037
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service